IDEAYA Biosciences Inc (NAS:IDYA)
$ 26.75 -0.7 (-2.55%) Market Cap: 2.31 Bil Enterprise Value: 1.47 Bil PE Ratio: 0 PB Ratio: 1.96 GF Score: 30/100

IDEAYA Biosciences Inc at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 04:30PM GMT
Release Date Price: $25.4 (+3.89%)
Maury Raycroft
Jefferies - Analyst

My name is Maury Raycroft, and I'm one of the BioTech analysts at Jefferies. And it is with great pleasure that I'd like to welcome the CEO of IDEAYA, Yujiro Hara and the CMO, Darrin Beaupre. They are both joining us today for a fireside chat discussion. Thanks so much for joining us.

Yujiro Hata
IDEAYA Biosciences Inc - President & CEO

Great. Thank you, Maury, for the kind introduction and thank you to Jefferies for the opportunity to participate this year at your event.

Maury Raycroft
Jefferies - Analyst

And maybe for those who are new to the story, you can give a 1-minute intro to IDEAYA.

Yujiro Hata
IDEAYA Biosciences Inc - President & CEO

Sure. So IDEAYA was founded 7.5 years ago. We're a leading precision medicine oncology, biotechnology company. Today, we have three first-in-class clinical programs. The first is darovasetib. Here, this is specifically targeting a genetic alteration called GNAQ/GNA11. The lead

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot